Multiple system atrophy (MSA) is a neurodegenerative disease belonging to group of synucleinopathies and characterized by significant autonomic failure, parkinsonian syndrome, cerebellar signs. Diagnostic criteria used currently were updated in 2022. While the clinical method neuroimaging are typically diagnostic MSA, new modalities emerging. Novel candidate biomarkers being intensively thoroug...